• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Device Classification Under Section 513(f)(2)(De Novo)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Device Classification Name circulating tumor cell (ctc) enrichment device
De Novo Number DEN200062
Device Name Parsortix PC1 Device
Requester
angle europe ltd.
10 nugent road
guildford,  GB gu2 7af
Contact andrew newland
Regulation Number866.6110
Classification Product Code
QSA  
Date Received09/28/2020
Decision Date 05/24/2022
Decision granted (DENG)
Classification Advisory Committee Immunology
Review Advisory Committee Molecular Genetics
Reclassification Order Reclassification Order
FDA Review Decision Summary
Type Direct
-
-